 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval% }! N3 j( a) {, ?4 F- D, D* z
4 t6 l1 u- t: M' z0 F% t
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.0 T4 J4 d( S: E1 ]
# E9 a4 |+ ]7 LBY THE EDMONTON JOURNAL FEBRUARY 16, 2007
/ u1 O0 E! p o4 K F6 d - ^1 N7 G. y1 x+ c
1 s; G+ s' ?9 U
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
4 _( k- G" p C7 J* R( D& F6 M$ S
7 w+ q8 F9 G# Q5 S0 \! jThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
7 w; M- H( d" D! Z$ n* D; g9 H* U W6 @+ D' \
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.0 X5 u P% B3 O @* ~3 T$ M6 m4 N
3 G$ u) A; {2 N8 V; v! r2 B y
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.6 T3 k: c3 H$ @
s, X$ N: i( |8 N$ t
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
1 `$ m. g G5 ], |7 G6 S6 c5 _$ E _; S+ c# L9 z& I$ x
"As a scientist, it's one of the highlights of my CAREER," Shan said.
/ c4 C ]6 C* t: ~7 w1 i Y. A& e, j5 [0 s" X
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
8 ^: t$ d* s4 ~1 J$ g' Q; {; Z/ {! H/ r: g0 C, k S5 y
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
8 w) ~% N( {5 w2 V2 D( J* z! t
/ x' R. y8 x) P# s$ pGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
/ ]# c& g( F+ s3 p5 c9 y; s4 x7 f& @# H9 _ E
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.+ \% W: H- C4 f1 r9 M- o
. G2 a/ O. A( p
6 t0 f; i& P: c! \+ Nhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
/ |" @. r: m$ W4 M3 F# j$ X
发表于 2015-2-28 19:45
